Stray radiation dose and second cancer risk for a pediatric patient receiving craniospinal irradiation with proton beams.
about
Monte Carlo fast dose calculator for proton radiotherapy: application to a voxelized geometry representing a patient with prostate cancer.The risk of developing a second cancer after receiving craniospinal proton irradiation.Influence of beam efficiency through the patient-specific collimator on secondary neutron dose equivalent in double scattering and uniform scanning modes of proton therapy.REDUCING STRAY RADIATION DOSE FOR A PEDIATRIC PATIENT RECEIVING PROTON CRANIOSPINAL IRRADIATIONEmerging role of radiation induced bystander effects: Cell communications and carcinogenesis.An exponential growth of computational phantom research in radiation protection, imaging, and radiotherapy: a review of the fifty-year history.Comparison of therapeutic dosimetric data from passively scattered proton and photon craniospinal irradiations for medulloblastomaEvaluation of energy deposition and secondary particle production in proton therapy of brain using a slab head phantomAn analytic model of neutron ambient dose equivalent and equivalent dose for proton radiotherapy.Risk of second malignant neoplasm following proton versus intensity-modulated photon radiotherapies for hepatocellular carcinomaA GPU implementation of a track-repeating algorithm for proton radiotherapy dose calculations.Predicted risks of second malignant neoplasm incidence and mortality due to secondary neutrons in a girl and boy receiving proton craniospinal irradiationADVANTAGES OF MCNPX-BASED LATTICE TALLY OVER MESH TALLY IN HIGH-SPEED MONTE CARLO DOSE RECONSTRUCTION FOR PROTON RADIOTHERAPY.Comparison of second cancer risk due to out-of-field doses from 6-MV IMRT and proton therapy based on 6 pediatric patient treatment plansInter-Institutional Comparison of Personalized Risk Assessments for Second Malignant Neoplasms for a 13-Year-Old Girl Receiving Proton versus Photon Craniospinal Irradiation.Implementation of an analytical model for leakage neutron equivalent dose in a proton radiotherapy planning system.Analytical model for out-of-field dose in photon craniospinal irradiationThe physics of proton therapy.External-beam accelerated partial breast irradiation using multiple proton beam configurations.First steps towards a fast-neutron therapy planning program.Reducing the cost of proton radiation therapy: the feasibility of a streamlined treatment technique for prostate cancer.Proton radiotherapy for solid tumors of childhood.Comparison of out-of-field photon doses in 6 MV IMRT and neutron doses in proton therapy for adult and pediatric patientsAssessment of the risk for developing a second malignancy from scattered and secondary radiation in radiation therapyRadiotherapy-induced malignancies: review of clinical features, pathobiology, and evolving approaches for mitigating riskComparison of risk of radiogenic second cancer following photon and proton craniospinal irradiation for a pediatric medulloblastoma patient.Secondary neutron dose measurement for proton eye treatment using an eye snout with a borated neutron absorberPredicted risks of radiogenic cardiac toxicity in two pediatric patients undergoing photon or proton radiotherapy.The predicted relative risk of premature ovarian failure for three radiotherapy modalities in a girl receiving craniospinal irradiation.Defining the role of proton therapy in the optimal management of paediatric patients in Australia and New Zealand.A scintillator-based approach to monitor secondary neutron production during proton therapy.Proton beam therapy in Japan: current and future status.A comparative study of dose distribution of PBT, 3D-CRT and IMRT for pediatric brain tumorsRange modulation in proton therapy planning: a simple method for mitigating effects of increased relative biological effectiveness at the end-of-range of clinical proton beams.Estimate of the uncertainties in the relative risk of secondary malignant neoplasms following proton therapy and intensity-modulated photon therapyMeasurement of absorbed dose, quality factor, and dose equivalent in water phantom outside of the irradiation field in passive carbon-ion and proton radiotherapies.Modeling intracranial second tumor risk and estimates of clinical toxicity with various radiation therapy techniques for patients with pituitary adenoma.AAPM TG 158: Measurement and calculation of doses outside the treated volume from external-beam radiation therapy.Experimental evaluation of neutron dose in radiotherapy patients: Which dose?The evolution of proton beam therapy: Current and future status.
P2860
Q34074405-5D0E47BE-6C3D-4BFB-B26B-A66AD9B52981Q34086830-B623D23D-283B-4E7A-A076-3895836F3FDDQ34126066-4A1B7879-3D85-45C7-AACC-464F0BF59946Q34145162-A407642D-1457-4061-A40D-FB2FE8276705Q34173857-F327684F-56B4-4310-BD1A-54187B68B918Q34217724-60DEA88D-DDFF-4AC5-99C7-5B5D8354CC8CQ34350198-669E4268-F5C0-4B34-81C1-9AE18C476C64Q34363612-810E03CC-F259-4006-B54B-07F014110E2AQ34402663-66DB6246-5BD1-41AF-BE24-9938A09E51B6Q34402676-D7103C3B-DBCA-446E-B616-7BC75A1C60A0Q34402777-B0AC181E-4727-46EB-BACB-78CCE7C698ADQ34402785-62D405E7-6468-4DE7-995A-79A0D79CC88AQ34575096-2AB1328D-F183-481F-8110-C8518B2F2D7DQ34666728-978B516D-B731-4C20-9485-5DD8532AF3FAQ35237529-E74194F0-B2FD-4440-81D1-7152F7616A05Q35237533-AB65A542-E82E-4A5A-BBE5-258F9ADF814AQ35398974-4FF74372-AC93-41E5-9A0E-38136987CB30Q35531022-2E2DA157-F83B-4331-B406-34A8C61AB1F2Q35644734-81927A70-C355-4054-8B34-1CFC519C259BQ35682466-842B3637-205A-4CB1-B797-FC91236A025EQ35818426-E935C134-93FD-4DEB-B46A-98F6A8BB2FBBQ35924026-343379F6-F500-4CB7-AAA1-98871F512E20Q36038142-8C88F0B5-7AF6-45AB-B660-F93884286F2FQ36298040-ED0DAF38-D184-4533-AD72-1D9CFE42AC9CQ36736612-7374FD6B-DC42-454C-A35D-204912597307Q36737527-EFC81F06-8B4F-4CAD-A2E5-FFC7BD1ADBDAQ37045565-D2F36A06-226E-42DC-9069-FF96770F6D31Q37114877-B96F30DF-9205-4771-AF85-16E2087889ECQ37419665-0EE112DD-2A8F-4587-BC93-CA7CD3C26AECQ38588047-B7AA2CF2-5DA5-4E35-B573-92CF385DDE65Q38799947-4BB4094B-F44C-481A-9EAF-7EF3B646CB2BQ38830371-AB1B0C0B-A55D-4982-8F8E-F764D5262B45Q41788821-CCE2EB11-830D-4B41-BBB5-D208787420BCQ41895634-A710E951-078F-4CE2-9EA1-09D18F373A05Q42020565-28C2C616-A0F2-40CC-8C6D-D109D058C435Q43930815-7D89151A-84A3-419C-A966-3594A141CBC7Q45357342-AAE3501E-41EB-4DDD-A3DE-A1E2E2F7A630Q47947282-1DD08A06-5030-4DF3-9507-8042F03D0416Q48888144-01BE3A4F-6FEE-4B80-8E56-FC43E1CBC4D4Q49333936-4AE7F4FF-9D25-48E7-B76B-AF80F4A15C6F
P2860
Stray radiation dose and second cancer risk for a pediatric patient receiving craniospinal irradiation with proton beams.
description
2009 nî lūn-bûn
@nan
2009 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի մարտին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Stray radiation dose and secon ...... irradiation with proton beams.
@ast
Stray radiation dose and secon ...... irradiation with proton beams.
@en
Stray radiation dose and secon ...... irradiation with proton beams.
@nl
type
label
Stray radiation dose and secon ...... irradiation with proton beams.
@ast
Stray radiation dose and secon ...... irradiation with proton beams.
@en
Stray radiation dose and secon ...... irradiation with proton beams.
@nl
prefLabel
Stray radiation dose and secon ...... irradiation with proton beams.
@ast
Stray radiation dose and secon ...... irradiation with proton beams.
@en
Stray radiation dose and secon ...... irradiation with proton beams.
@nl
P2093
P2860
P356
P1476
Stray radiation dose and secon ...... irradiation with proton beams.
@en
P2093
Annelise Giebeler
David Kornguth
Dragan Mirkovic
Jonas D Fontenot
Phillip J Taddei
Wayne D Newhauser
Yuanshui Zheng
P2860
P304
P356
10.1088/0031-9155/54/8/001
P577
2009-03-20T00:00:00Z